首页 | 本学科首页   官方微博 | 高级检索  
     

肝血流同步双栓治疗中、晚期肝癌的临床研究
引用本文:宋蔚青,宋涛,李晓明,卢云,何曙生,张继光. 肝血流同步双栓治疗中、晚期肝癌的临床研究[J]. 西安交通大学学报(医学版), 1996, 0(2)
作者姓名:宋蔚青  宋涛  李晓明  卢云  何曙生  张继光
作者单位:西安第一临床医学院外科,陕西省肿瘤医院
摘    要:我院1989年10月~1995年3月对57例中晚期肝癌患者进行肝血流同步双栓(经腹肝动脉、门静脉双置管同时注入化疗栓塞剂)治疗。结果半年生存率为94.1%。1年66.6%,2年31.3%,3年5.8%。该方法明显优于单纯肝动脉化疗栓塞,安全可靠,操作简单,术后并发症少,是中晚期肝癌综合治疗中较理想的方法。

关 键 词:中晚期肝癌;肝动脉门静脉同步双相化疗栓塞;肝脏储备功能

THE CLINICAL SUTDY ON THE TREATMENT OF INTERMEDIATE-ADVANCED LIVER CARCINOMA BY SIMULATANEOUS EMBOLIZATION OF BOTH HEPATIC ARTERY AND PORTAL VEIN
Song Weiqing, Song Tao,Li xiaoming,et al. THE CLINICAL SUTDY ON THE TREATMENT OF INTERMEDIATE-ADVANCED LIVER CARCINOMA BY SIMULATANEOUS EMBOLIZATION OF BOTH HEPATIC ARTERY AND PORTAL VEIN[J]. Journal of Xi‘an Jiaotong University:Medical Sciences, 1996, 0(2)
Authors:Song Weiqing   Song Tao  Li xiaoming  et al
Abstract:This article reports that 51 patients with intermediate advanced liver cancer were treatedby the method of simultaneous embolization of hepatic blood vessels from Oct.1989 to Mar.1995in our hospital. Through abdomen putting cathetersinto hepatic artery and portal vein and injecting chemoembolization substance at the same time, the overall survival rate in half year, 1 year, 2 years, 3years was 94.1%, 66.6%,31.3%,5.8% respectively. This method is apparently better than simple hepatic artery embolization.This procedure is safe and simple and has few complications. So we can say it is an excellent combined treatement for intermediate-advanced tumor of liver.
Keywords:intermediate-advanced carcinoma of liver  simultaneous embolization of both hepatic artery and portal vein  hepatic reserve function  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号